Arivin Therapeutics, a Finnish-Dutch biotech spin-off from Aalto University and the University of Helsinki, has raised €3 million in seed funding to advance therapies for drug-resistant bacterial infections.
Arivin Therapeutics, a Finnish-Dutch biotech spin-off from Aalto University and the University of Helsinki, has raised €3 million in seed funding to advance therapies for drug-resistant bacterial infections.
Amsterdam-based crypto-asset provider Amdax has raised €20 million in its initial financing round for the Amsterdam Bitcoin Treasury Strategy (AMBTS), a new vehicle designed to give institutional investors regulated exposure to Bitcoin.
Framer, the Amsterdam-based no-code website design platform, has raised $100 million (€85.6M) in a Series D round led by existing investors Meritech and Atomico, with participation from WiL (World Innovation Lab) and HV Capital.
The Hague-based fintech startup UpToMore has raised €3 million in funding to fuel the rollout of its radically simple investment app — a platform its founders boldly claim to be “the most boring investment app in the Netherlands.”
Enschede-based QuiX Quantum has raised €15 million in a Series A round to accelerate the development of its first-generation universal photonic quantum computer.
Amsterdam’s Biotech Booster programme has received €196.4 million from the Dutch National Growth Fund, solidifying support for its mission to bridge the gap between biotechnology research and market applications.
Amsterdam-based climate tech company Dexter Energy has raised €23 million in Series C funding to scale its AI-powered trading platform for renewable energy.
